Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ujjaini Dasgupta

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Oncoscience|April 22, 2021
Alternative splicing of CERS2 promotes cell proliferation and migration in luminal B subtype breast cancer cellsTrishna Pani, Kajal Rajput, Animesh Kar, et al.
Biomedical Materials (Bristol, England)|January 18, 2021
Advances in engineering of low molecular weight hydrogels for chemotherapeutic applicationsSanjay Pal, Devashish Mehta, Ujjaini Dasgupta, et al.
Translational Oncology|February 11, 2024
Insights into molecular mechanisms of chemotherapy resistance in cancerAnimesh Kar, Shivam Agarwal, Agrata Singh, et al.
ACS Pharmacology & Translational Science|December 19, 2024
Unveiling the Role of Mechanistic Target of Rapamycin Kinase (MTOR) Signaling in Cancer Progression and the Emergence of MTOR Inhibitors as Therapeutic StrategiesDevashish Mehta, Kajal Rajput, Dolly Jain, et al.
Briefings in Bioinformatics|January 22, 2023
Prediction of transcript structure and concentration using RNA-Seq dataHarsh Sharma, Trishna Pani, Ujjaini Dasgupta, et al.
Development Genes and Evolution|July 5, 2007
Functional conservation of the human EXT1 tumor suppressor gene and its Drosophila homolog tout veluUjjaini Dasgupta, Bharat L Dixit, Melissa Rusch, et al.
Nanoscale Advances|February 19, 2025
Docetaxel-conjugated bile acid-derived nanomicelles can inhibit tumour progression with reduced toxicityDevashish Mehta, Chhavi Dua, Ruchira Chakraborty, et al.
Msphere|August 21, 2020
Identification of Genomewide Alternative Splicing Events in Sequential, Isogenic Clinical Isolates of Candida albicans Reveals a Novel Mechanism of Drug Resistance and Tolerance to Cellular StressesSuraya Muzafar, Ravi Datta Sharma, Abdul Haseeb Shah, et al.
Cancers|September 23, 2022
Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer CellsKajal Rajput, Mohammad Nafees Ansari, Somesh K Jha, et al.
Nanoscale|September 17, 2020
Hydrogel-mediated delivery of celastrol and doxorubicin induces a synergistic effect on tumor regression via upregulation of ceramidesNihal Medatwal, Mohammad Nafees Ansari, Sandeep Kumar, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Oncoscience|April 22, 2021
Alternative splicing of CERS2 promotes cell proliferation and migration in luminal B subtype breast cancer cellsTrishna Pani, Kajal Rajput, Animesh Kar, et al.
Biomedical Materials (Bristol, England)|January 18, 2021
Advances in engineering of low molecular weight hydrogels for chemotherapeutic applicationsSanjay Pal, Devashish Mehta, Ujjaini Dasgupta, et al.
Translational Oncology|February 11, 2024
Insights into molecular mechanisms of chemotherapy resistance in cancerAnimesh Kar, Shivam Agarwal, Agrata Singh, et al.
ACS Pharmacology & Translational Science|December 19, 2024
Unveiling the Role of Mechanistic Target of Rapamycin Kinase (MTOR) Signaling in Cancer Progression and the Emergence of MTOR Inhibitors as Therapeutic StrategiesDevashish Mehta, Kajal Rajput, Dolly Jain, et al.
Briefings in Bioinformatics|January 22, 2023
Prediction of transcript structure and concentration using RNA-Seq dataHarsh Sharma, Trishna Pani, Ujjaini Dasgupta, et al.
Development Genes and Evolution|July 5, 2007
Functional conservation of the human EXT1 tumor suppressor gene and its Drosophila homolog tout veluUjjaini Dasgupta, Bharat L Dixit, Melissa Rusch, et al.
Nanoscale Advances|February 19, 2025
Docetaxel-conjugated bile acid-derived nanomicelles can inhibit tumour progression with reduced toxicityDevashish Mehta, Chhavi Dua, Ruchira Chakraborty, et al.
Msphere|August 21, 2020
Identification of Genomewide Alternative Splicing Events in Sequential, Isogenic Clinical Isolates of Candida albicans Reveals a Novel Mechanism of Drug Resistance and Tolerance to Cellular StressesSuraya Muzafar, Ravi Datta Sharma, Abdul Haseeb Shah, et al.
Cancers|September 23, 2022
Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer CellsKajal Rajput, Mohammad Nafees Ansari, Somesh K Jha, et al.
Nanoscale|September 17, 2020
Hydrogel-mediated delivery of celastrol and doxorubicin induces a synergistic effect on tumor regression via upregulation of ceramidesNihal Medatwal, Mohammad Nafees Ansari, Sandeep Kumar, et al.
Pageof 3